Literature DB >> 26354751

Hypoxia-inducible factors in T lymphocyte differentiation and function. A Review in the Theme: Cellular Responses to Hypoxia.

Jin-Hui Tao1, Joseph Barbi2, Fan Pan3.   

Abstract

Low oxygen concentrations or hypoxia is a trait common to inflamed tissues. Therefore it is not surprising that pathways of hypoxic stress response, largely governed by hypoxia-inducible factors (HIF), are highly relevant to the proper function of immune cells. HIF expression and stabilization in immune cells can be triggered not only by hypoxia, but also by a variety of stimuli and pathological stresses associated with leukocyte activation and inflammation. In addition to its role as a sensor of oxygen scarcity, HIF is also a major regulator of immune cell metabolic function. Rapid progress is being made in elucidating the roles played by HIF in diverse aspects of both innate and adaptive immunity. Here we discuss a number of breakthroughs that have shed light on how HIF expression and activity impact the differentiation and function of diverse T cell populations. The insights gained from these findings may serve as the foundation for future therapies aimed at fine-tuning the immune response.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  T cells; hypoxia-inducible factor; immune activation; inflammation; metabolism

Mesh:

Substances:

Year:  2015        PMID: 26354751      PMCID: PMC4628938          DOI: 10.1152/ajpcell.00204.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  64 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  HIF-1 and human disease: one highly involved factor.

Authors:  G L Semenza
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

3.  Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch.

Authors:  Patrick M Gubser; Glenn R Bantug; Leyla Razik; Marco Fischer; Sarah Dimeloe; Gideon Hoenger; Bojana Durovic; Annaïse Jauch; Christoph Hess
Journal:  Nat Immunol       Date:  2013-08-18       Impact factor: 25.606

Review 4.  Metabolism in T cell activation and differentiation.

Authors:  Erika L Pearce
Journal:  Curr Opin Immunol       Date:  2010-02-26       Impact factor: 7.486

5.  Human TH17 cells are long-lived effector memory cells.

Authors:  Ilona Kryczek; Ende Zhao; Yan Liu; Yin Wang; Linhua Vatan; Wojciech Szeliga; Jeffrey Moyer; Aleksandra Klimczak; Andrzej Lange; Weiping Zou
Journal:  Sci Transl Med       Date:  2011-10-12       Impact factor: 17.956

Review 6.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

7.  Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa.

Authors:  Eric T Clambey; Eóin N McNamee; Joseph A Westrich; Louise E Glover; Eric L Campbell; Paul Jedlicka; Edwin F de Zoeten; John C Cambier; Kurt R Stenmark; Sean P Colgan; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

8.  Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.

Authors:  Andrew L Doedens; Anthony T Phan; Martin H Stradner; Jessica K Fujimoto; Jessica V Nguyen; Edward Yang; Randall S Johnson; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2013-09-29       Impact factor: 25.606

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.

Authors:  David K Finlay; Ella Rosenzweig; Linda V Sinclair; Carmen Feijoo-Carnero; Jens L Hukelmann; Julia Rolf; Andrey A Panteleyev; Klaus Okkenhaug; Doreen A Cantrell
Journal:  J Exp Med       Date:  2012-11-26       Impact factor: 14.307

View more
  33 in total

1.  Hypoxic modulation of hepatocyte responses to the cytokine interleukin-22.

Authors:  Scott A Budda; Krishna Bhattarai; Justine L Alexander; Lauren A Zenewicz
Journal:  Immunol Cell Biol       Date:  2016-10-31       Impact factor: 5.126

2.  Rhein enhances the cytotoxicity of effector lymphocytes in colon cancer under hypoxic conditions.

Authors:  Xiangfei Yuan; Wencong Tian; Yang Hua; Lijuan Hu; Jing Yang; Junmuzi Xie; Jiacai Hu; Feng Wang
Journal:  Exp Ther Med       Date:  2018-10-12       Impact factor: 2.447

Review 3.  Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis.

Authors:  Essa M Sabi; Anuja Singh; Ziyad M Althafar; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Hosam M Alqahtani; Simona Bungau
Journal:  Inflammopharmacology       Date:  2022-04-01       Impact factor: 4.473

4.  Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia.

Authors:  Nicole E Scharping; Ashley V Menk; Ryan D Whetstone; Xue Zeng; Greg M Delgoffe
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

Review 5.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

6.  Hypoxia and Innate Immunity: Keeping Up with the HIFsters.

Authors:  Sean P Colgan; Glenn T Furuta; Cormac T Taylor
Journal:  Annu Rev Immunol       Date:  2020-01-21       Impact factor: 28.527

Review 7.  Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy.

Authors:  David H Munn; Madhav D Sharma; Theodore S Johnson
Journal:  Cancer Res       Date:  2018-09-04       Impact factor: 12.701

8.  Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma.

Authors:  Yu Hei; Binhong Teng; Ziqian Zeng; Siqi Zhang; Qian Li; Jijia Pan; Zuyuan Luo; Chunyang Xiong; Shicheng Wei
Journal:  Int J Nanomedicine       Date:  2020-03-10

Review 9.  Hypoxia/HIF Modulates Immune Responses.

Authors:  Yuling Chen; Timo Gaber
Journal:  Biomedicines       Date:  2021-03-05

10.  Differential transcriptional and functional properties of regulatory T cells in HIV-infected individuals on antiretroviral therapy and long-term non-progressors.

Authors:  Shima Shahbaz; Juan Jovel; Shokrollah Elahi
Journal:  Clin Transl Immunology       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.